James Battiste

University Of Oklahoma Hlth Sciences Ctr

$857,092

Attributed

$857,092

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $217.5K · FY2018–21

$250K$187.5K$125K$62.5K$0

'18

'19

'20

'21

Funding mix

By agency

NIH$857,092 · 1

By mechanism

P20$857,092 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Oklahoma Hlth Sciences Ctr

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Combined Modality Therapy”

Barbara Burtness · Yale University$11,235,253
Jurgen Bernd Bulitta · State University Of New York At Buffalo$7,090,719
Kathleen N. Moore · University Of Oklahoma$6,686,608
Nilu Goonetilleke · Univ Of North Carolina Chapel Hill$6,073,977
Feixiong Cheng · Cleveland Clinic Lerner Com-Cwru$5,834,007
Nader Fotouhi · Global Alliance For Tb Drug Development$5,472,466

Research focus

Combined Modality TherapyAntibodiesAtp-Binding Cassette TransportersAbcg2 GeneBaseBasement MembraneBindingBiologicalAxonAftercareBrainBrain ParenchymaCandidate Disease GeneCell Culture TechniquesCell LineCell MotilityCellsCell SurvivalBiophysical PropertiesChemotherapyBiophysicsClinically RelevantClone CellsConfined Spaces

Grant awards (4)

Analysis of Migration Associated Treatment Resistance in Glioblastoma to Identify Novel Therapeutics$210,318

P20 · FY2021 · GM · contact PI

Analysis of Migration Associated Treatment Resistance in Glioblastoma to Identify Novel Therapeutics$213,668

P20 · FY2020 · GM · contact PI

Analysis of Migration Associated Treatment Resistance in Glioblastoma to Identify Novel Therapeutics$215,606

P20 · FY2019 · GM · contact PI

Analysis of Migration Associated Treatment Resistance in Glioblastoma to Identify Novel Therapeutics$217,500

P20 · FY2018 · GM · contact PI